Zika-Associated Microcephaly Can Present After Birth

Researchers report on more than a dozen cases in which babies who showed signs of in-utero infection but were born without symptoms of congenital Zika syndrome went on to develop brain abnormalities.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, CDCNine baby boys and four baby girls with laboratory evidence of congenital Zika virus infection, who did not appear to have microcephaly or related neurological conditions at birth, went on to develop brain abnormalities associated with congenital Zika syndrome, researchers from Brazil and the U.S. reported today (November 22) in the Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report. While the babies’ at-birth head circumferences did not meet the criteria for microcephaly diagnoses, upon later neurologic and neuroimaging evaluations at health care centers in Brazil, researchers identified Zika-associated complications.

“Congenital microcephaly has been a hallmark of intrauterine infection with Zika virus,” the authors wrote in their report. “However, despite the absence of microcephaly at birth, the 13 infants in this report with laboratory evidence of Zika virus infection had brain abnormalities associated with congenital Zika syndrome, including ventriculomegaly and decreased brain volume, cortical malformations and subcortical calcifications, underscoring the importance of neuroimaging in evaluating these infants.”

Of the 13 infants studied, 11 went on to develop microcephaly, according to a CDC statement.

“This report documents that microcephaly at birth is not an essential hallmark of congenital Zika syndrome. Infants with normal HC [head circumference] at birth have brain and other abnormalities associated with congenital Zika syndrome and might develop microcephaly after birth,” the authors ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies